NRDC to help Andhra Pradesh government start agribusiness incubation centers
10 Jun 2016
The Andhra Pradesh government through its AP Food Processing Society has entered into a memorandum of agreement (MoA) with the National Research Development Corporation (NRDC), to strengthen the agribusiness and food processing sector by establishing smart agribusiness platform networks of Andhra Pradesh (SAPNAP).
These networks will focus on creation of enabling ecosystem for accelerated growth of agribusiness by involving all the stakeholders.
SAPNAP will have two key development platforms – Smart Agribusiness Value-chains and Smart Agribusiness Incubators and Accelerators. Smart Agribusiness Value Chains will focus on intelligence / analytics / big data, innovations and partnerships while the Smart Agribusiness incubators will focus on establishment of 13 district level incubators with enabling infrastructure and ecosystem for start ups, enterprise development and FPO mentoring.
NRDC will act as the knowledge partner in the programme and would provide the required technologies, know-how, IPRs and other value-added techno-commercial services to the start-ups of SAPNAP and linkages to the national and international stakeholders.
NRDC, an enterprise of the Department of Scientific and Industrial Research, under the ministry of science and technology also entered into a license agreement with Chaturbhuj Pharmaceutical Co, Haridwar for commercialization of Ayush-82, an ayurvedic formulation for management of diabetes.
Ayush-82 was developed by Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, an autonomous organisation under the ministry of AYUSH (Ayurveda, Yoga, Unani, Siddha and Homeopathy).
NRDC has so far licensed 13 ayurvedic technologies developed by CCRAS to more than 33 companies in India.
Ayush-82 is a combination of known and tested hypoglycemic drugs. Its clinical studies have been done extensively. Diabetes mellitus is a group of metabolic diseases marked by high level of blood glucose resulting from defects in insulin production, insulin action or both.
